SPNT Earnings

SPNT reported its earnings on 2026-02-18, showcasing a revenue of 973.70M against an estimate of 776.05M, resulting in a 25.47% surprise. The EPS was 0.7, surpassing the expected 0.54 by 29.63%. The stock experienced a 7% price change on the earnings day and a 2.82% change over the next five days, reflecting market reactions to the results.

Following SPNT's earnings announcement on 2026-02-18, the stock price moved by 7% on the day of the release. Over the subsequent five days, it saw a 2.82% change. Historically, SPNT's stock price tends to shift by an average of -1.31% in the 10 days leading up to earnings and 6.07% in the 10 days following, providing insight into potential market.

For 2026/Q1, analysts estimate SPNT's annual revenue to reach 760.90M, while the EPS is projected at 0.68. These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between SPNT's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were unchanged by 0%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, SPNT's stock price typically moves by -1.31% in the 10 days before its earnings and 6.07% in the 10 days after. For the upcoming 2026/Q1 earnings, analysts expect an EPS of 0.68 and revenue of 760.90M.

The earnings call highlights strong financial performance, including a 49% increase in EPS and a 141% increase in net income. The strategic focus on high-return segments like Accident & Health and Surety, along with a disciplined approach to underwriting and expense management, is promising. Despite some uncertainties in the Q&A, the overall sentiment is positive, with sustainable growth and a $100 million buyback program likely to support stock price appreciation. The company's market cap suggests a moderate reaction, leading to a positive prediction of 2% to 8% increase.